AZAlexander Zarour

Alexander Zarour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander Zarour has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Christian J. Bachmann

    Klinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie, Universitätsklinikum Ulm, Deutschland

    1 shared publication
  • Constanze Scholman

    Department of Otorhinolaryngology, Head and Neck Surgery University of Groningen, University Medical Centre Groningen Groningen the Netherlands

    1 shared publication
  • Falk Hoffmann

    Department of Health Services Research, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany

    1 shared publication
  • Jakob Holstiege

    Department of Epidemiology and Healthcare Atlas, Central Research Institute of Ambulatory Health Care in Germany , Berlin

    1 shared publication
  • Lisa Dandolo

    Universitätsklinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik, Carl von Ossietzky Universität Oldenburg und Klinikum Oldenburg AöR, Oldenburg

    1 shared publication
  • Yulia Golub

    Universitätsklinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik, Carl von Ossietzky Universität Oldenburg und Klinikum Oldenburg AöR, Oldenburg

    1 shared publication

Latest Publications

  • Open Access

    Trends in the diagnostic prevalence of cannabis-related disorders and co-occurring psychiatric disorders in adolescents: analysis of German health insurance data from 2013 to 2022

    by Alexander Zarour, Christian Bachmann, Lisa Dandolo, Jakob Holstiege, Falk Hoffmann, Constanze Scholman, Yulia Golub

    Cannabis use can have detrimental effects on adolescents’ mental health, often co-occurring with child and adolescent psychiatric disorders (CAPD). This study assessed diagnostic prevalence trends in cannabis-related disorders and co-occurring diagnosed CAPD in adolescents receiving outpatient treatment in Germany. Outpatient claims data from the national public health insurance system, covering almost 4 million children and adolescents, were assessed for diagnostic prevalence of cannabis-related disorders (ICD-10 diagnoses F12.X) in insurees aged 12 to 17 years for the years 2013–22, stratified by age group and sex. In addition, the diagnostic prevalence of co-occurring CAPD during the year 2022 was evaluated. From 2013 to 2022, the diagnostic prevalence of cannabis-related disorders among German adolescents utilizing outpatient services increased from 0.08% to 0.10% (+22.4%), with a decline during the COVID-19 pandemic and a higher diagnostic prevalence in older adolescents. Up to 14 years of age, the diagnostic prevalence of cannabis-related disorders was distributed evenly among males and females, while from age 15 onwards, the diagnostic prevalence was higher in males. Overall, 78.3% of adolescents diagnosed with cannabis-related disorders had at least one co-occurring CAPD diagnosis in 2022. Most common co-occurring conditions were depressive disorders, conduct disorders, adjustment disorders, attention-deficit/hyperactivity disorders, and anxiety disorders. Co-occurring depression was particularly often diagnosed, underscoring the urgent need for integrated treatment approaches addressing both disorders simultaneously in this age group.